Hayward Holdings delivered a clean beat on both lines in the third quarter and raised full-year guidance for the second time. That record is strong, but it sits awkwardly against a stock that has fallen hard since the last report. Adjusted EPS of $0.18 topped the $0.15 consensus by 20.0% and grew 28.6% year over year. Revenue of $260.13 million beat the $252.0 million estimate by 3.2% and rose 6.5%. The central tension is that execution keeps improving while top-line momentum is cooling. Third-quarter sales growth trailed the 8% year-to-date pace, and management's guidance implies fourth-quarter sales only flat to up 3%.
The quality of the earnings beat deserves scrutiny, because much of the profit leverage came from below the gross-profit line. Consolidated gross margin rose just 10 basis points to 47.9%, and only because of a richer mix toward North America. Gross margin actually declined modestly in both segments as inflation slightly outran pricing. The GAAP operating margin jump of 250 basis points to 19.3% was flattered by the absence of a $2.8 million litigation charge in the prior-year period. Several other items helped as well. Net interest expense fell 30% to $7.9 million. The diluted share count dropped to 216.5 million from 222.4 million on buybacks. The normalized tax rate used for adjusted results eased to 22.5% from 24.5%. Adjusted EBITDA grew a more modest 9%, with margin up 60 basis points to 24.8%, which is a fairer read of core operating leverage.
North America remains the engine. Segment sales rose 9%, with roughly 7 points from price and 2 points from volume, marking a third straight quarter of positive volume. Adjusted segment margin improved 80 basis points to 30.4%. Management described its share gains more assertively than earlier in the year, calling them durable and broad-based. It also said 2027 early-buy orders in North America are running ahead of last year. International was the weak spot. Europe & Rest of World sales fell 6%, hit by Middle East disruption and a Europe decline of 18% tied to the timing of Wuxi shipments; management put the adjusted segment decline nearer 1%. Canada fell 9% on tariff uncertainty after rising 26% in the first quarter.
The forward signals are genuinely mixed. On the positive side, management pointed to a late third-quarter price increase meant to cover inflation into 2027. It also expects a COVID-era installed-base replacement cycle to begin over roughly the next year. The CFO said repurposing the Wuxi facility to serve Europe is likely incremental to the prior European margin plan. Bears, however, have legitimate ammunition. Channel partners are modestly trimming days on hand, a shift from the second-quarter view that no step-down was expected, and fourth-quarter guidance allows for further tightening. Early-buy pricing for 2027 is lower than last year, and inflation is running slightly above mid-single digits. The industry is coalescing around flat 2027 volumes, while permits and new construction remain soft. Year-to-date operating cash flow fell to $225 million from $283 million on working-capital build. The roughly $200 million free cash flow target was held, though, and net leverage sits at 1.5x, the lowest since the IPO. Year-to-date buybacks reached about $115 million, up from $64 million at midyear.
The guidance raise itself was measured. Adjusted EPS guidance moved to $0.86–$0.88 from $0.84–$0.87, which Earnings Whispers characterizes as in line with estimates. The midpoint rose by less than the size of the third-quarter beat, implying a cautious fourth quarter. The sales outlook moved to 5%–6% growth from about 5%.
The market setup is more complicated than the surprise implies. Shares closed at $13.03 ahead of the report, down 18.7% from the $16.03 open after the July release. They sat about 10.6% below the 200-day moving average of $14.58. The stock set a 52-week low of $11.24 on October 12 and has since rebounded nearly 16% off that level, but it remains more than 20% below the inter-earnings high. Investor sentiment improved modestly, rising to 0.23 from 0.17, a positive but hardly euphoric reading. Price and AVWAP trend signals remain negative, consistent with a stock that has been sold despite steady upward revisions.
The bottom line is that Hayward is executing well, gaining share in North America, and returning more capital, but the quarter's earnings strength leaned on mix, interest savings, buybacks, and lapping a litigation charge rather than on gross-margin expansion. With fourth-quarter growth set to slow, channel inventories edging lower, and 2027 shaping up as a price-sensitive, flat-volume year, the beat-and-raise narrows the debate rather than settling it. Investors will be watching whether early-buy volume and the replacement cycle can offset softer pricing.